DNA Sequencing Firm Illumina Wants To Fight Cancer With Grail, A 'Liquid Biopsy' To Detect Cancer San Diego-based DNA sequencing company Illumina plans to build startup Grail to offer liquid biopsy to the market. This cancer blood test is promoted by CEO Jay Flatley as the "turning point" in the war on cancer. by Katrina Pascual
Science New cfDNA test more effective in determining Down Syndrome in fetus, than standard serum screening by Maryanne Moll
Healthy Living/Wellness Illumina $1000 HiSeq X Ten genome sequencing machine will shake up health industry by Alex Saltarin